OCT interpretation; Emerging therapies in AMD; Macular Sx Update; Patient Privacy
Date: 28/08/2019
Venue: Campbelltown Rydges, Bookman-Rockwell room,15 Menangle road, Campbelltown , NSW, 2560
Provider: INSERVIO PTY LTD - Sponsor
Contact: INSERVIO PTY LTD, [E] Tina.Xenoulis@inservio.com.au, [P] 0432808708
Learning Objectives
- Understand retinal pathology in an OCT
- Explain the principles and applications of an OCT
- Identify various common disease state by OCT testing
- be aware of current treatment for AMD and their efficacy
- understand the different available treatments for Dry and wet AMD
- be aware of new treatments and their availability for AMD
- Understand the timing and need for macular surgery
- Determine the urgency of referral for macular surgery
- Understand available options and patient information for macular surgery
- List ways that health care workers can protect their patients’ personal information.
- Define the requirements of notifiable data breaches for certain types of breaches involving patient personal information.
- Identify the leading cause of data breaches in the Australian private health care sector.
Max points awarded: 6.67
Session Information
| Name |
|---|
| OCT interpretations |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |
| Name |
|---|
| Emerging therapies in AMD |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |
| Name |
|---|
| Macular Sx Update |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |
| Name |
|---|
| Patient privacy and the Australian health care sector |
| Activity Type |
| Non Clinical |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 0.67 |
| Name | Activity Type | Therapeutic? | Manufacturer/Supplier? | Points for attending & Passing Assessment |
|---|---|---|---|---|
| OCT interpretations | Face to Face with Assessment | No | No | 2.00 |
| Emerging therapies in AMD | Face to Face with Assessment | No | No | 2.00 |
| Macular Sx Update | Face to Face with Assessment | No | No | 2.00 |
| Patient privacy and the Australian health care sector | Non Clinical | No | No | 0.67 |